20140314 - Mar 14, 2014
ISSUE 11 – MARCH 14, 2014PDF


NCI Rethinks Cancer Center Grants

 

NCI is moving toward adopting a formula that will fundamentally restructure the manner in which cancer centers are funded.

The new approach, developed by a working group of the National Cancer Advisory Board, seeks to eliminate the advantage that comes with a center’s longevity in the program.

As it stands, just being in the centers program for many cycles can build up an institution’s funding base. This favors older centers. 

photoRobert Cook-Deegan’s Viewers’ Guide To the Super Bowl of Gene Patent Cases

Patent litigation is a blood sport if you see corporations as people and count spilled ink or loss of money as hemorrhage. 

One of the most closely watched cases in recent years centers on genetic testing for BRCA1 and BRCA2 genes. 

On March 10, Judge Robert Shelby from the Federal District Court for Utah denied Myriad Genetics’ motion for a preliminary injunction against its competitors that had entered the market starting June 13, 2013, when the Supreme Court handed down its ruling in Association of Molecular Pathology v. Myriad Genetics.

20140307 - Mar 7, 2014
ISSUE 10 – MARCH 7, 2014PDF


NIH to Review Intramural Program

NCI’s Intramural Spending is 17 Percent, Higher than 11.1 Percent NIH-Wide Level


NIH has launched a systematic examination of its intramural program, which accounts for 11.1 percent of its $30 billion budget.

The program was last examined in 1993, pursuant to a mandate from the House Appropriations Committee.

That examination was written by a panel co-chaired by Paul Marks, then president of Memorial Sloan-Kettering Cancer Center and Gail Cassell, then chair of the University of Alabama Department Microbiology.

photoPresident Requests Extra $200 Mil for NIH

President Barack Obama’s $3.9-trillion budget proposal for the 2015 fiscal year would bump NIH funding up to $30.2 billion—a $200 million increase over fiscal 2014—and would include an additional $8 million for NCI, totaling $4.931 billion for the institute.

photoHPV Vaccines Should be Priority, says President’s Cancer Panel

Human papillomavirus vaccines are underused in the U.S. and need to be made a national public health priority, according to a report from the President’s Cancer Panel.
In a presentation to the National Cancer Advisory Board Feb. 27, panel chair Barbara Rimer outlined three goals to accelerate uptake of HPV vaccines, including having providers strongly encourage HPV vaccination to adolescents when other vaccines are being administered.

photoNCI Publishes Report on Pancreatic Cancer

NCI has issued a report detailing a “scientific framework” for advancing research on pancreatic ductal adenocarcinoma, indicating potential new funding opportunities for genomic studies for early detection of pancreatic cancer.

The institute’s report is the result of the Recalcitrant Cancer Research Act, a bill proposed by the Pancreatic Cancer Action Network, and passed Jan. 2, 2013.

photoIn Brief

  • Pasche named center director at Wake Forest Baptist Medical Center
  • Jiali Han named Rachel Cecile Efroymson Professor in Cancer Research at the Indiana University Simon Cancer Center
  • Carol Bier-Laning will lead CTCA Head and Neck Cancer Program
  • Curie-Cancer renews partnership with DNA Therapeutics
  • A correction
20140228 - Feb 28, 2014
ISSUE 9 – FEB. 28, 2014PDF

Groups Have No Budgets as NCTN Begins Work March 1

Two years ago, NCI officials made a promise to increase the budget of the cooperative groups program by $25.6 million.

The boost, which was approved by the NCI Board of Scientific Advisors, was part of an effort to revamp the groups inspired by a report from the Institute of Medicine.

On March 1, as the cooperative group program officially becomes the NCI National Clinical Trials Network, new money will not be a part of the transformation. 

photoNCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

The contractor running the Frederick National Laboratory for Cancer Research received nearly $300 million from NCI in the 2013 fiscal year, and is slated for an increase, officials said at a recent advisory committee meeting.

photoIn Brief

  • Van Andel Research Institute to build epigenetics hub

  • Jennifer Doudna named winner of the Foundation for the NIH’s Lurie Prize

  • GRU Cancer Center receives $6 million committment

  • Twenty-six public health organizations call for retailers to stop selling tobacco products

  • ION Solutions selects Foundation Medicine for genomic profiling services

  • Mylan launches first Herceptin biosimilar

  • NeoGenomics launches profiling tests covering 22 cancer categories

  • Clarient adds BRAF diagnostic to its service offerings